“Proteomics expects to meet with the FDA to progress its clearance within 10 weeks. If PromarkerD...
Milestone first patent for Proteomics simple endometriosis test – The Age
In a milestone moment, ASX-listed diagnostics innovator Proteomics International Laboratories has achieved its first patent globally in Japan for its simple “traffic light” diagnostic blood test for endometriosis.
The decision will protect the company’s intellectual property rights for its PromarkerEndo technology in the world’s fourth-largest healthcare market until March 16, 2041.